Created at 12:16 p.m. Sep, 26, 2024
Author:
DillingerMed
Type of change:
Updated content
Rationale for change
See current suggestion in nid:1542852438440
https://next.amboss.com/us/article/580iM3
Current
Suggested
Text
Text
Text
Text
Extra
- Note: As of 2022, USPSTF NO LONGER recommends initiating low-dose ASA in patients with >10% 10-year CVD risk. Decision should be made on a case by case basis. They also lowered the age range from 50-59 (old) to 40-59 (new)
- They also removed the ASA for CRC prevention recommendation. Sources are split on this subject and some still recommend ASA for CRC prevention
- *USPSTF no longer has recommendations for routine lipid screening in healthy adults; see Archived - Lipid Disorders in Adults: Screening
- Screening recommendations per AMBOSS and the 2019 ACC/AHA guideline are from 20 - 75 years old
- They also removed the ASA for CRC prevention recommendation. Sources are split on this subject and some still recommend ASA for CRC prevention
- *USPSTF no longer has recommendations for routine lipid screening in healthy adults; see Archived - Lipid Disorders in Adults: Screening
- Screening recommendations per AMBOSS and the 2019 ACC/AHA guideline are from 20 - 75 years old
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Empty field
Sketchy
Empty field
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Empty field
OME
Additional Resources
Sources:
https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer
https://www.aafp.org/afp/2019/0601/p670.html
https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer
https://www.aafp.org/afp/2019/0601/p670.html
One by one
Empty field